A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer

Nutrition

Volumn 32, Issue 11-12, 2016, Pages 1231-1237

  Sandini, Marta ^a   Bernasconi, Davide P ^b   Fior, Davide ^a   Molinelli, Matilde ^a   Ippolito, Davide ^a   Nespoli, Luca ^a   Caccialanza, Riccardo ^c   Gianotti, Luca ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Body composition; Morbidity; Obesity; Pancreas; Sarcopenia; Surgery

Indexed keywords

ABDOMINAL WALL MUSCULATURE; ABSCESS; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BILE LEAKAGE; BODY HEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART DISEASE; HUMAN; INFECTIOUS COMPLICATION; INTRAPERITONEAL FAT; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; PANCREAS CANCER; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SARCOPENIA; SENSITIVITY AND SPECIFICITY; SEPSIS; SURGICAL INFECTION; URINARY TRACT INFECTION; VISCERAL ADIPOSE TISSUE TO SKELETAL MUSCLE RATIO; X-RAY COMPUTED TOMOGRAPHY; ADVERSE EFFECTS; BODY COMPOSITION; BODY MASS; DIAGNOSTIC IMAGING; INTRAABDOMINAL FAT; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREATIC NEOPLASMS; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; SKELETAL MUSCLE;

AGED; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MUSCLE, SKELETAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA;

EID: 84973904845     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.04.002     Document Type: Article

References (51)

1. [1] Büchler, M.W., Wagner, M., Schmied, B.M., Uhl, W., Friess, H., Z'graggen, K., Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003), 1310–1314.
2. [2] Cameron, J.L., Riall, T.S., Coleman, J., Belcher, K.A., One thousand consecutive pancreaticoduodenectomies. Ann Surg 244 (2006), 10–15.
3. [3] Uzunoglu, F.G., Reeh, M., Vettorazzi, E., Ruschke, T., Hannah, P., Nentwich, M.F., et al. Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score. Ann Surg 260 (2014), 857–863.
4. [4] Friedman, J., Lussiez, A., Sullivan, J., Wang, S., Englesbe, M., Implications of sarcopenia in major surgery. Nutr Clin Pract 30 (2015), 175–179.
5. [5] Shimizu, A., Tani, M., Kawai, M., Hirono, S., Miyazawa, M., Uchiyama, K., et al. Influence of visceral obesity for postoperative pulmonary complications after pancreaticoduodenectomy. J Gastrointest Surg 15 (2011), 1401–1410.
6. [6] House, M.G., Fong, Y., Arnaoutakis, D.J., Sharma, R., Winston, C.B., Protic, M., et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12 (2008), 270–278.
7. [7] Kirihara, Y., Takahashi, N., Hashimoto, Y., Sclabas, G.M., Khan, S., Moriya, T., et al. Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition. Ann Surg 257 (2013), 512–519.
8. [8] Sandini, M., Bernasconi, D.P., Ippolito, D., Nespoli, L., Baini, M., Barbaro, S., et al. Preoperative computed tomography to predict and stratify the risk of severe pancreatic fistula after pancreatoduodenectomy. Medicine, 94, 2015, e1152.
9. [9] Zalite, O., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., et al. Influence of cachexia and sarcopenia on survival in pancreatic adenoarcinoma: a systematic review. Pancreatology 15 (2015), 19–24.
10. [10] Peng, P., Hyder, O., Firoozmand, A., Kneurtz, P., Schulick, R.D., Huang, D., et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 16 (2012), 1478–1486.
11. [11] Lodewick, T.M., Roeth, A.A., Steven, W.M., Olde Damink, S.W., Alizai, P.H., van Dam, R.M., et al. Sarcopenia, obesity and sarcopenic obesity: Effects on liver function and volume in patients scheduled for major liver resection. J Cachexia Sarcopenia Muscle 6 (2015), 155–163.
12. [12] Cooper, C., Dere, W., Evans, W., Kanis, J., Rizzoli, R., Sayer, A., et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 23 (2012), 1839–1848.
13. [13] Kim, S.W., Han, H.S., Jung, H.W., Kim, K.I., Hwang, D.W., Kang, S.B., et al. Multidimensional Frailty Score for the prediction of postoperative mortality risk. JAMA Surg 149 (2014), 633–640.
14. [14] Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., Sy-Onge, M.P., Albu, J., et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97 (2004), 2333–2338.
15. [15] Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M.T., McCargar, L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (2013), 1539–1547.
16. [16] Bozzetti, F., Braga, M., Gianotti, L., Gavazzi, C., Mariani, L., Postoperative enteral verus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet 358 (2001), 1487–1492.
17. [17] Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
18. [18] Gaujoux, S., Cortes, A., Couvelard, A., Noullet, S., Clavel, L., Rebours, V., et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 148 (2010), 15–23.
19. [19] Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A., Yeo, C., Izbicki, J., et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138 (2005), 8–13.
20. [20] Rota, M., Antolini, L., Finding the optimal cut-point for gaussian and gamma distributed biomarkers. Comput Stat Data Anal 69 (2014), 1–14.
21. [21] Yamashita, T., Yamashita, K., Kamimura, R., A stepwise AIC method for variable selection in linear regression. Commun Stat Theory Methods 36 (2007), 2395–2403.
22. [22] Hubbard, R.E., Story, D.A., Patient frailty: the elephant in the operating room. Anaesthesia 69:suppl 1 (2014), 26–34.
23. [23] McMillan, M.T., Vollmer, C.M. Jr., Evaluating the efficacy of pre-operative fistula risk assessment. HPB (Oxford) 17 (2015), 373–374.
24. [24] Weinberg, L., Wong, D., Karalapillai, D., Pearce, B., Tan, C.O., Tay, S., et al. The impact of fluid intervention on complications and length of hospital stay after pancreaticoduodenectomy (Whipple's procedure). BMC Anesthesiol 14 (2014), 14–35.
25. [25] Roberts, K.J., Hodson, J., Mehrzad, H., Marudanayagam, R., Sutcliffe, R.P., Muiesan, P., et al. A preoperative predictive score of pancreatic fistula following pancreatoduodenectomy. HPB (Oxford) 16 (2014), 620–628.
26. [26] McAuliffe, J.C., Parks, K., Kumar, P., McNeal, S.F., Morgan, D.E., Christein, J.C., Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy. HPB (Oxford) 15 (2013), 709–715.
27. [27] Dindo, D., Muller, M.K., Weber, M., Clavien, P.A., Obesity in general elective surgery. Lancet 361 (2003), 2032–2035.
28. [28] Pierpont, Y.N., Dinh, T.P., Salas, R.E., Johnson, E.L., Wright, T.G., Robson, M.C., et al. Obesity and surgical wound healing: a current review. ISRN Obes, 2014, 2014, 638936.
29. [29] De Lorenzo, A., Bianchi, A., Maroni, P., Iannarelli, A., Di Daniele, N., Iacopino, L., et al. Adiposity rather than BMI determines metabolic risk. Int J Cardiol 166 (2013), 111–117.
30. [30] Prado, C.M., Lieffers, J.R., McCargar, L.J., Reiman, T., Sawyer, M.B., Martin, L., et al. Prevalence of clinical implications of sarcopenic obesity in patients with solid tumors of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9 (2008), 629–635.
31. [31] Frozanpor, F., Loizou, L., Ansorge, C., Segersvärd, R., Lundell, L., Albiin, N., Preoperative pancreas CT/MRI characteristics predict fistula rate after pancreaticoduodenectomy. World J Surg 36 (2012), 1858–1865.
32. [32] Tranchart, H., Gaujoux, S., Rebours, V., Vullierme, M.P., Dokmak, S., Levy, P., et al. Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg 256 (2012), 139–145.
33. [33] Amini, N., Spolverato, G., Gupta, R., Margonis, G.A., Kim, Y., Wagner, D., et al. Impact total psoas volume on short- and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia. J Gastrointest Surg 19 (2015), 1593–1602.
34. [34] Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
35. [35] Cederholm, T., Bosaeus, I., Barazzoni, R., Bauer, J., Van Gossum, A., Klek, S., et al. Diagnostic criteria for malnutrition—an ESPEN Consensus Statement. Clin Nutr 34 (2015), 335–340.
36. [36] Wozniak, S.E., Gee, L.L., Wachtel, M.S., Frezza, E.E., Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54 (2009), 1847–1856.
37. [37] Jia, S., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O.D., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 (2004), 1318–1327.
38. [38] Bekri, S., Gual, P., Anty, R., Luciani, N., Dahman, M., Ramesh, B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131 (2006), 788–796.
39. [39] Tilg, H., Moschen, A.R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006), 772–783.
40. [40] Argilés, J.M., Busquets, S., Stemmler, B., López-Soriano, F.J., Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol 22 (2015), 100–106.
41. [41] Rollins, K.E., Tewari, N., Ackner, A., Awwad, A., Madhusudan, S., Macdonald, I.A., et al. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 35 (2016), 765–766.
42. [42] Tan, B.H., Birdsell, L.A., Martin, L., Baracos, V.E., Fearon, K.C., Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15 (2009), 6973–6979.
43. [43] Jarosz, P.A., Bellar, A., Sarcopenic obesity: an emerging cause of frailty in older adults. Geriatr Nurs 30 (2009), 64–70.
44. [44] Baumgartner, R.N., Body composition in healthy aging. Ann N Y Acad Sci 904 (2000), 437–448.
45. [45] Du, Y., Karvellas, C.J., Baracos, V., Williams, D.C., Khadaroo, R.G., Acute Care and Emergency Surgery (ACES) Group. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 156 (2014), 521–527.
46. [46] Kob, R., Bollheimer, L.C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C.C., et al. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?. Biogerontology 16 (2015), 15–29.
47. [47] Tani, M., Kawai, M., Hirono, S., Ina, S., Miyazawa, M., Nishioka, R., et al. A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age. J Hepatobiliary Pancreat Surg 16 (2009), 675–680.
48. [48] Suzuki, S., Kaji, S., Koike, N., Harada, N., Suzuki, M., Pancreaticoduodenectomy can be safely performed in the elderly. Surg Today 43 (2013), 620–624.
49. [49] Coolsen, M.M., Bakens, M., van Dam, R.M., Olde Damink, S.W., Dejong, C.H., Implementing an enhanced recovery program after pancreaticoduodenectomy in elderly patients: is it feasible?. World J Surg 39 (2015), 251–258.
50. [50] Norman, K., Stobäus, N., Pirlich, M., Bosy-Westphal, A., Bioelectrical phase angle and impedance vector analysis—clinical relevance and applicability of impedance parameters. Clin Nutr 31 (2012), 854–861.
51. [51] Gillis, C., Li, C., Lee, L., Awasthi, R., Augustin, B., Gamsa, A., et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology 121 (2014), 937–947.